Phosphorus metabolism and fibroblast growth factor 23 in chronic kidney disease
A Bansal, M Chonchol - Nutritional management of renal disease, 2022 - Elsevier
… treatments led to increased phosphate clearance per week and resulted in a decrease in the
use of phosphate binders … shown to help preserve kidney function, this effect could be due …
use of phosphate binders … shown to help preserve kidney function, this effect could be due …
The impact of phosphate lowering agents on clinical and laboratory outcomes in chronic kidney disease patients: a systematic review and meta-analysis of …
J Phannajit, N Wonghakaeo, K Takkavatakarn… - Journal of …, 2022 - Springer
… in chronic kidney disease (CKD) patients, phosphate lowering agents might provide beneficial
effects … Phosphate lowering agents include phosphate binders (PBs), blockers of intestinal …
effects … Phosphate lowering agents include phosphate binders (PBs), blockers of intestinal …
The relationship between circulating endothelial microparticles and arterial stiffness and atherosclerosis in children with chronic kidney disease
I Dursun, HM Poyrazoglu, Z Gunduz… - Nephrology Dialysis …, 2009 - academic.oup.com
… Our results suggest that endothelial damage starts in the early stage of CKD, that the …
The high value of EMP levels in our patients may have pathophysiological effects on the …
The high value of EMP levels in our patients may have pathophysiological effects on the …
Phosphate–the silent stealthy cardiorenal culprit in all stages of chronic kidney disease: a systematic review
… the effects of plasma phosphate on adverse cardiovascular outcome, … levels are subjected
to dietary control at this early stage of … phosphate binders or inhibitors of phosphate absorption …
to dietary control at this early stage of … phosphate binders or inhibitors of phosphate absorption …
FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages
L Desjardins, S Liabeuf, C Renard, A Lenglet… - Osteoporosis …, 2012 - Springer
… In patients with chronic kidney disease (CKD), circulating … CKD, (2) be taking phosphate
binders, and (3) have higher … levels and vascular calcification in early-stage CKD patients with …
binders, and (3) have higher … levels and vascular calcification in early-stage CKD patients with …
Optimal management of hyperphosphatemia in end-stage renal disease: an Indian perspective
YN Reddy, V Sundaram, G Abraham… - … Disease, 2014 - Taylor & Francis
… in the incidence of chronic kidney disease (CKD) from … Through the aforementioned effects
on the kidney, there is a … Citation38 Phosphate binders are the primary treatment tool for …
on the kidney, there is a … Citation38 Phosphate binders are the primary treatment tool for …
Arterial and cardiac disease in young adults with childhood-onset end-stage renal disease—impact of calcium and vitamin D therapy
S Briese, S Wiesner, JC Will, A Lembcke… - Nephrology Dialysis …, 2006 - academic.oup.com
… regarding the effect of calcium-containing phosphate binders and … an early stage in the
development of uraemic arterial and … with chronic renal failure and after renal transplantation. …
development of uraemic arterial and … with chronic renal failure and after renal transplantation. …
Can We Tackle with Vascular Calcification and Arterial Stiffness in Patients with Chronic Kidney Disease?
E Stavrinou, A Papagianni, C Koumaras… - The Open …, 2013 - benthamopen.com
… In this context, sevelamer, a non-calcium based phosphate binder, was asso… Effect of
spironolactone on left ventricular mass and aortic stiffness in early-stage chronic kidney disease: a …
spironolactone on left ventricular mass and aortic stiffness in early-stage chronic kidney disease: a …
Medial and intimal calcification in chronic kidney disease: stressing the contributions
… But phosphate binder therapy reportedly has no effect on … Effects of phosphate binder
therapy on vascular stiffness in early‐stage chronic kidney disease. Am J Nephrol. 2013; 38:158–…
therapy on vascular stiffness in early‐stage chronic kidney disease. Am J Nephrol. 2013; 38:158–…
Vascular Calcification and Cardiovascular Risk in Chronic Kidney Disease: A Problem That Is Here to Stay
ECE Carias, RC Marques… - … Cardiovascular Disease, 2021 - books.google.com
… but not yet proven to be a cause-effect [28, 29] and some opinions still … phosphate diet
showed that aortic medial calcification could be blocked by treatment with the phosphate binder…
showed that aortic medial calcification could be blocked by treatment with the phosphate binder…